Kunin M et al. |
Mycobacterium chelonae peritonitis in peritoneal dialysis. Literature review. |
2014 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:24569948
|
Seung KJ et al. |
Salvage therapy for multidrug-resistant tuberculosis. |
2014 |
Clin. Microbiol. Infect. |
pmid:23991934
|
Yakoob J et al. |
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori. |
2014 |
Microb. Drug Resist. |
pmid:23844851
|
Bjerre M et al. |
Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. |
2014 |
Scand. J. Clin. Lab. Invest. |
pmid:25026506
|
Khoshnood A et al. |
Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of Helicobacter pylori: A randomized clinical trial. |
2014 |
J Med Life |
pmid:25408735
|
Noh TK et al. |
Infection with Mycobacterium fortuitum during acupoint embedding therapy. |
2014 |
J. Am. Acad. Dermatol. |
pmid:24831334
|
Fowler J and Mahlen SD |
Localized cutaneous infections in immunocompetent individuals due to rapidly growing mycobacteria. |
2014 |
Arch. Pathol. Lab. Med. |
pmid:25076301
|
Ueda Y et al. |
[Obstructive pneumonia and brain abscess due to Nocardia elegans in a patient with systemic lupus erythematosus]. |
2014 |
Kansenshogaku Zasshi |
pmid:24974451
|
NegrÃn-González J et al. |
Psychiatric adverse reaction induced by clarithromycin. |
2014 |
Eur Ann Allergy Clin Immunol |
pmid:24853570
|
Loreto ES et al. |
New insights into the in vitro susceptibility of Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25223997
|
Tümgör G et al. |
Comparison of standard and standard plus vitamin E therapy for Helicobacter pylori eradications in children. |
2014 |
Turk J Gastroenterol |
pmid:25910378
|
Lee JY et al. |
Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance. |
2014 |
Dig. Dis. Sci. |
pmid:24599773
|
Zhao HM et al. |
[Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori infection in children]. |
2014 |
Zhongguo Dang Dai Er Ke Za Zhi |
pmid:24661511
|
Ohe M and Hashino S |
Successful treatment of primary immune thrombocytopenia in aged patients using clarithromycin. |
2014 |
J. Formos. Med. Assoc. |
pmid:24630039
|
Zhou L et al. |
A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial. |
2014 |
Am. J. Gastroenterol. |
pmid:24642580
|
Heo J and Jeon SW |
[Changes in the eradication rate of conventional triple therapy for Helicobacter pylori infection in Korea]. |
2014 |
Korean J Gastroenterol |
pmid:24651586
|
Kang BK et al. |
[New therapeutic strategies against Helicobacter pylori]. |
2014 |
Korean J Gastroenterol |
pmid:24651587
|
Patsche CB et al. |
Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement. |
2014 |
Int. J. Infect. Dis. |
pmid:25008771
|
Mendu ML and Waikar SS |
Drug-drug interactions and acute kidney injury: caveat prescriptor. |
2014 |
Am. J. Kidney Dis. |
pmid:24820318
|
de Masson A et al. |
Cavitary pulmonary disease in a patient treated with natalizumab. |
2014 |
Presse Med |
pmid:24742610
|
Furuta T et al. |
Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan. |
2014 |
J. Gastroenterol. Hepatol. |
pmid:24224808
|
Noguchi S et al. |
Polymorphic transformation of antibiotic clarithromycin under acidic condition. |
2014 |
J Pharm Sci |
pmid:24375227
|
Methaneethorn J et al. |
A pharmacokinetic drug-drug interaction model of simvastatin and clarithromycin in humans. |
2014 |
Conf Proc IEEE Eng Med Biol Soc |
pmid:25571290
|
Hajaghamohammadi A et al. |
Low dose furazolidone for eradication of H- pylori instead of clarithromycin: a clinical trial. |
2014 |
Glob J Health Sci |
pmid:25560342
|
Iwanczak B et al. |
Genotypic and clinical differences of seropositive Helicobacter pylori children and adults in the Polish population. |
2014 |
J. Physiol. Pharmacol. |
pmid:25554984
|
Rakici H et al. |
Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of Helicobacter pylori as first-line therapy. |
2014 |
Digestion |
pmid:25547786
|
Kim SY et al. |
[Ten day concomitant therapy is superior to ten day sequential therapy for Helicobacter pylori eradication]. |
2014 |
Korean J Gastroenterol |
pmid:25420735
|
Mustafa G and Necati B |
Clarithromycin-associated rhabdomyolysis in an infant. |
2014 |
J Clin Rheumatol |
pmid:25417692
|
Hashim H et al. |
Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease. |
2014 |
PLoS ONE |
pmid:25411976
|
Yangco BG et al. |
Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART? |
2014 |
AIDS Patient Care STDS |
pmid:24833016
|
Klis S et al. |
Compliance with antimicrobial therapy for buruli ulcer. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25225342
|
Mitui M et al. |
Novel Helicobacter pylori sequencing test identifies high rate of clarithromycin resistance. |
2014 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:25222804
|
Gold BD |
Resistance testing for Helicobacter pylori infection: is it finally ready for prime time? |
2014 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:25222802
|
Morakul B et al. |
Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization method. |
2014 |
Eur J Pharm Biopharm |
pmid:25201298
|
Martin JH and Coombes I |
Mortality from common drug interactions systems, knowledge and clinical reasoning to optimise prescribing. |
2014 |
Intern Med J |
pmid:25041768
|
Bansal S and Chhibber S |
Phytochemical-induced reduction of pulmonary inflammation during Klebsiella pneumoniae lung infection in mice. |
2014 |
J Infect Dev Ctries |
pmid:25022293
|
Fouka E et al. |
Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients. |
2014 |
Lung |
pmid:25016929
|
Lambert D et al. |
Gastritis due to Helicobacter pylori, an unusual cause of chronic diarrhoea in HIV infected patients. |
2014 |
Med Mal Infect |
pmid:25015308
|
Gong EJ et al. |
Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change? |
2014 |
J. Korean Med. Sci. |
pmid:24851029
|
Jeon HK and Kim GH |
Does standard triple therapy still have a role in first-line Helicobacter pylori eradication in Korea? |
2014 |
J. Korean Med. Sci. |
pmid:24851014
|
Rasheed F et al. |
Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance. |
2014 |
Helicobacter |
pmid:24827414
|
Wang Y et al. |
Efficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis. |
2014 |
Helicobacter |
pmid:24826809
|
Graham DY et al. |
Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. |
2014 |
Clin. Gastroenterol. Hepatol. |
pmid:23751282
|
Pan-In P et al. |
Ethyl cellulose nanoparticles: clarithomycin encapsulation and eradication of H. pylori. |
2014 |
Carbohydr Polym |
pmid:24815396
|
Wu JY et al. |
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate. |
2014 |
Helicobacter |
pmid:24612093
|
Settin A et al. |
Cure rate of Helicobacter pylori infection in Egyptian children related to CYP2C19 gene polymorphism. |
2014 |
Indian J Gastroenterol |
pmid:24610583
|
Garza-González E et al. |
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. |
2014 |
World J. Gastroenterol. |
pmid:24587620
|
Okame M et al. |
Complete regression of early-stage gastric diffuse large B-cell lymphoma in an HIV-1-infected patient following Helicobacter pylori eradication therapy. |
2014 |
Clin. Infect. Dis. |
pmid:24585569
|
Mark TM et al. |
Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma. |
2014 |
Leuk. Lymphoma |
pmid:24576165
|
Takazono T et al. |
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report. |
2014 |
BMC Infect. Dis. |
pmid:24576098
|